Biopharma industry questions potential AstraZeneca, Bristol Myers mergernews2026-08-03T19:20:35+00:00August 3rd, 2026|Endpoints News|
RFK Jr. interview sparks corrections on vaccines, pandemics and measlesnews2026-08-03T18:47:35+00:00August 3rd, 2026|Endpoints News|
FDA expands Pluvicto label, making it available to most metastatic prostate cancer patientsnews2026-08-03T15:26:14+00:00August 3rd, 2026|Endpoints News|
Curium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing casenews2026-08-03T14:28:13+00:00August 3rd, 2026|Endpoints News|
Work ethic becomes a flashpoint as China’s biotech pace quickensnews2026-08-03T14:00:18+00:00August 3rd, 2026|Endpoints News|
Supernus, Indivior to merge and form CNS-focused drugmakernews2026-08-03T11:24:44+00:00August 3rd, 2026|Endpoints News|
BioNTech names Sobi’s Guido Oelkers as incoming CEOnews2026-08-03T11:07:53+00:00August 3rd, 2026|Endpoints News|
Dash Bio raises $30M Series A led by Oak HC/FTnews2026-08-03T11:00:07+00:00August 3rd, 2026|Endpoints News|
Hackers steal patient data in Amgen cloud breachnews2026-08-03T10:47:59+00:00August 3rd, 2026|Endpoints News|
AstraZeneca, Bristol Myers in talks about merger — reportnews2026-08-02T20:27:37+00:00August 2nd, 2026|Endpoints News|